Assessing Teva Pharmaceutical Industries (TEVA) Valuation After A Sharp Multi‑Month Share Price Rally
Teva Pharmaceutical Industries (TEVA) is back on many investors’ screens after a period of strong recent returns, with the stock up about 10% over the past month and about 63% over the past 3 months.
See our latest analysis for Teva Pharmaceutical Industries.
Beyond the recent rally, Teva Pharmaceutical Industries has shown building momentum, with a 1 year total shareholder return of 60.42% and a 3 year total shareholder return near 2x. The latest share price sits at $32.79.
If Teva’s recent move has your attention, this could be a good moment to scan other healthcare names using the healthcare stocks and see what else matches your criteria.
With Teva trading at $32.79, an intrinsic value estimate implying a 53% discount and a…
